Vulvectomy ProcedureDescription, Latest Information and Doctors
Learn About Vulvectomy
Advocate Medical Group Oncology
Ismail Mert is an Oncologist in Chicago, Illinois. Dr. Mert is rated as an Experienced provider by MediFind in Vulvectomy. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ectopic Pregnancy, Vulvectomy, and Hysterectomy.
UPMC Magee-Womens Gynecologic Oncology
Dr. Sukumvanich is a specialized surgeon and gynecologic oncologist, specializing in the treatment of gynecologic and breast cancers. He serves as an assistant professor in the School of Medicine, and his research centers on the genetic causes of ovarian and breast cancers, and also cancer informatics (the science of analyzing large amounts of information). Dr. Sukumvanich is rated as a Distinguished provider by MediFind in Vulvectomy. His top areas of expertise are Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Vulvectomy, and Hysterectomy.
Montefiore Medical Park At Eastchester
Ken Yu Lin, MD, is an Associate Professor, Obstetrics & Gynecology and Women’s Health at Montefiore Einstein. He provides comprehensive, compassionate evidence-based care for women with gynecologic cancers. Dr. Lin performs radical cancer surgery and minimally invasive surgery using laparoscopy and the da Vinci robotic platform. Dr. Lin is rated as an Advanced provider by MediFind in Vulvectomy. His top areas of expertise are Vulvar Cancer, Malignant Mixed Mullerian Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, and Vulvectomy.
Summary: The researchers are doing this study to see if giving people fluorescein sodium as an IV infusion before their vulvectomy for treating extramammary Paget's disease (EMPD) can help surgeons with performing the procedure. The researchers will look at whether fluorescein sodium helps surgeons identify disease cells that should be removed. Other purposes of this study include looking at the following:...
Summary: This study is an open label, prospective, experimental, randomised clinical trial. The primary aim of this study is to determine whether it is feasible to randomise vulvar cancer patients into one of two treatment arms:1) surgical groin node dissection (as delivered though either a sentinel node biopsy or inguinofemoral lymph node dissection (IFL), or 2) serial high-resolution bilateral groin ultr...